Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

0.00%

20.5¢ raptor resources limited

Ann: Positive Results for Australian Prospective Paediatric Study, page-84

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 84 Last

Share
Profile

Follow
pilko3

6,851 Posts.

885

03/09/18

13:07

Post #: 35374679
Share

Originally posted by dman0 ↑

Worth re-posting from last week for the many new investors that will come to this forum now that positive Australian results are out and ResAppDx algorithms have been validated.

Good Aus pedi results = TGA + CE approvals

It might also mean CFDA approvals!!

"China is planning to accept data generated from clinical trials run overseas. The proposal is part of a suite of changes put forward by the State Council to boost China’s support for innovative drugs and devices and accelerate their path to patients."

See this link:
https://www.raps.org/news-articles/...ial-data-for-accelerated-approvals-(10-octobe

This would be MASSIVE. The telehealth numbers in China are staggering.

In 2017 PingAn had 370,000 telehealth consults per day and was growing at +100% per year (this is not a typo).

We are told that 30-50% of all consults are for respiratory disease. That's around 100k - 200k consults for respiratory disease per day and at only $5/test this is USD 500k - 1m revenue per day!

The opportunity in the China market is huge. The potential revenue numbers are staggering.

There is no other product on the market like ResAppDx.

Currently a steal at 0.26 IMO.

Expand

China alone should be worth north of a $billion per year to RAP gross in the next couple of years. Mind-boggling numbers whichever way you do the sums!

RAP Price at posting: 25.5¢ Sentiment: Buy Disclosure: Held
9 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The market's shrugged at China's stimulus measures all year. Why is this one different?

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

The winners & losers on market if negative gearing were gone

There are more pages in this discussion • 286 more messages in this thread...

First 84 Last

Add RAP (ASX) to my watchlist

Ann: Positive Results for Australian Prospective Paediatric Study, page-84

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The market's shrugged at China's stimulus measures all year. Why is this one different?

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

ACCC seeks Olam divestments before it can buy Namoi Cotton

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

The winners & losers on market if negative gearing were gone

Featured News